New staging classification for pancreatic neuroendocrine neoplasms combining TNM stage and WHO grade classification [ ]

Cives, 2018, Gastroenteropancreatic neuroendocrine tumors, CA A Cancer J. Clin., 68, 471, 10.3322/caac.21493 Hua, 2020, Expression patterns and prognostic value of DNA damage repair proteins in resected pancreatic neuroendocrine neoplasms [published online ahead of print, 2020 Mar 20], Ann. Surg. Hong, 2020, Whole-genome sequencing reveals distinct genetic bases for insulinomas and non-functional pancreatic neuroendocrine tumours: leading to a new classification system, Gut, 69, 877, 10.1136/gutjnl-2018-317233 Zaidi, 2019, A novel validated recurrence risk score to guide a pragmatic surveillance strategy after resection of pancreatic neuroendocrine tumors: an international study of 1006 patients, Ann. Surg., 270, 422, 10.1097/SLA.0000000000003461 Wen, 2020, The eighth edition of the American joint committee on cancer distant metastases stage classification for metastatic pancreatic neuroendocrine tumors might be feasible for metastatic pancreatic ductal adenocarcinomas, Neuroendocrinology, 110, 364, 10.1159/000502382 Zhang, 2020, Development and validation of a modified eighth AJCC staging system for primary pancreatic neuroendocrine tumors [published online ahead of print, 2020 Jun 4], Ann. Surg. Falconi, 2016, ENETS consensus guidelines update for the management of patients with functional pancreatic neuroendocrine tumors and non-functional pancreatic neuroendocrine tumors, Neuroendocrinology, 103, 153, 10.1159/000443171 Nagtegaal, 2020, The 2019 WHO classification of tumours of the digestive system, Histopathology, 76, 182, 10.1111/his.13975 Choe, 2019, What is new in the 2017 World Health Organization classification and 8th American Joint Committee on Cancer staging system for pancreatic neuroendocrine neoplasms?, Korean J. Radiol., 20, 10.3348/kjr.2018.0040 Luo, 2017, Modified staging classification for pancreatic neuroendocrine tumors on the basis of the American joint committee on cancer and European neuroendocrine tumor society systems, J. Clin. Oncol., 35, 274, 10.1200/JCO.2016.67.8193 Hijioka, 2015, Does the WHO 2010 classification of pancreatic neuroendocrine neoplasms accurately characterize pancreatic neuroendocrine carcinomas?, J. Gastroenterol., 50, 564, 10.1007/s00535-014-0987-2 Akirov, 2019, Treatment options for pancreatic neuroendocrine tumors, Cancers, 11, 828, 10.3390/cancers11060828 Han, 2018, Clinical relevance of different WHO grade 3 pancreatic neuroendocrine neoplasms based on morphology, Endocr Connect, 7, 355, 10.1530/EC-17-0388 Pusceddu, 2018, A classification prognostic score to predict OS in stage IV well-differentiated neuroendocrine tumors, Endocr. Relat. Canc., 25, 607, 10.1530/ERC-17-0489 Young, 2020, The molecular biology of pancreatic neuroendocrine neoplasms: challenges and translational opportunities, Semin. Canc. Biol., 61, 132, 10.1016/j.semcancer.2019.09.024 You, 2019, Validation of the 8th AJCC cancer staging system for pancreas neuroendocrine tumors using Korean nationwide surgery database, Cancer Res Treat, 51, 1639, 10.4143/crt.2019.023 Amin, 2017, The eighth edition AJCC cancer staging manual: continuing to build a bridge from a population‐based to a more “personalized” approach to cancer staging, CA A Cancer J. Clin., 67, 93, 10.3322/caac.21388 Inzani, 2018, The new World Health organization classification for pancreatic neuroendocrine Neoplasia, Endocrinol Metab. Clin. N. Am., 47, 463, 10.1016/j.ecl.2018.04.008 Ishida, 2020, Pancreatic neuroendocrine neoplasms: the latest surgical and medical treatment strategies based on the current World Health Organization classification, Crit. Rev. Oncol. Hematol., 145, 102835, 10.1016/j.critrevonc.2019.102835 Howe, 2020, The North American neuroendocrine tumor society consensus paper on the surgical management of pancreatic neuroendocrine tumors, Pancreas, 49, 1, 10.1097/MPA.0000000000001454 Hackeng, 2021, Non-functional pancreatic neuroendocrine tumours: ATRX/DAXX and alternative lengthening of telomeres (ALT) are prognostically independent from ARX/PDX1 expression and tumour size, Gut, 10.1136/gutjnl-2020-322595 Genç, 2018, A new scoring system to predict recurrent disease in grade 1 and 2 nonfunctional pancreatic neuroendocrine tumors, Ann. Surg., 267, 1148, 10.1097/SLA.0000000000002123 Özaslan, 2016, Best prognostic factor of neuroendocrine tumors: grade or Stage? A multidisciplinary single-center study, Turk. J. Gastroenterol., 27, 509, 10.5152/tjg.2016.16391 Dasari, 2017, Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States, JAMA Oncol, 3, 1335, 10.1001/jamaoncol.2017.0589 Wang, 2019, Consideration of age is necessary for increasing the accuracy of the AJCC TNM staging system of pancreatic neuroendocrine tumors, Front Oncol, 9, 906, 10.3389/fonc.2019.00906